Article
Published 30 Jun 2025
Update On Biosimilars In Canada – June 2025
Smart & Biggar
Your search returned 1,476 results
Refine Your Search
Search Results
- Relevance
- Newest
- Oldest
Article
Published 30 Jun 2025
Updated PMPRB Guidelines Expected In Summer 2025 And NPDUIS Releases Ninth Edition Of The Meds Entry Watch Report
Smart & Biggar
Article
Published 26 Jun 2025
La nouvelle ébauche de la Ligne directrice de Santé Canada sur les médicaments biologiques biosimilaires
Fasken (French)
Article
Published 25 Jun 2025
Health Canada Consultation On Revised Biosimilar Guidance: No Requirement For Comparative Clinical Efficacy And Safety Trials
Smart & Biggar
Article
Published 20 Jun 2025
Biosimilar Update: Health Canada Reconsiders Requirement For Comparative Clinical Trials
McCarthy Tétrault LLP
Article
Published 5 Jun 2025
Apotex Not Entitled To Damages For Delayed Generic Drug Launch
Tierney Stauffer LLP
Article
Published 30 May 2025
CDA Update: New Five-Year Strategic Plan And Position Statement On Using AI In Health Technology Assessments
Smart & Biggar
Article
Published 21 May 2025
Les incidences du projet de loi 83 sur les médecins et le système de santé du Québec
Fasken (French)
Article
Published 16 May 2025
2024 Deal Points Report: Venture Capital Financings
Osler, Hoskin & Harcourt LLP
Article
Published 16 May 2025
Court Finds Eculizumab Patent Neither Anticipated Nor Obvious
Aitken Klee
Article
Published 8 May 2025
Health Canada Temporarily Exempts Newly Licensed Natural Health Products From New Labelling Requirements
Fasken
Article
Published 8 May 2025
Santé Canada exempte temporairement les produits de santé naturels nouvellement homologués des nouvelles exigences d'étiquetage
Fasken (French)
Article
Published 7 May 2025
5 Key Trends Shaping The Life Sciences Industry (Video)
RSM Canada
Article
Published 5 May 2025
Licensing Partnerships In Life Sciences: Emerging And Expected Trends In 2025
Gowling WLG
Article
Published 5 May 2025
Instruments médicaux basés sur l'IA — Transformation et réglementation
McCarthy Tétrault LLP
Article
Published 2 May 2025
Some Things Last Forever: Government Of Canada Proposes Regulatory Measures For PFAS
Osler, Hoskin & Harcourt LLP
Article
Published 1 May 2025
Health Canada Seeks Input On New Draft Guidance For Co-packaged Drug Products
Smart & Biggar
Article
Published 1 May 2025
Canada's Drug Agency Releases 2025 Watch List Highlighting AI Technologies In Health Care
Smart & Biggar
Article
Published 23 Apr 2025
Trade War Update: Relief For Some As Canada Orders Six-Month Reprieve On Retaliatory Tariffs On A Wide Range Of Imported Goods
McCarthy Tétrault LLP
Article
Published 23 Apr 2025
Who Owns A Thought? Navigating Legal Issues In Neurotech
McMillan LLP